Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Sanara MedTech Inc.NASDAQ: SMTI

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses remains negative

Q1 FY2026 other income / expenses was -$2.25M, compared with -$1.45M a year earlier. Trailing-twelve-month other income / expenses was -$10.36M.

Context

  • Other income / expenses amounted to 9.3% of revenue in FY2025, up 5.6 pp from a year earlier.
  • Other income / expenses grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other income / expenses holds near -$2.25M or moves back toward the trailing-twelve-month quarterly average of -$2.59M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$2.25M+43.8% QoQ
Last fiscal yearDec 2025
-$9.54M-198.4% YoY
LTMMar 2026
-$10.36M-136.8% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-55.5%——
1 year-198.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
(9.54M) USD
Year-over-year change
-198.4%

Other Income / Expenses vs competitors

How SMTI compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -136.8% is the 6th highest of 10, against a peer median of -32.7%.
  • Other income / expenses amounts to 9.6% of revenue for SMTI, versus a peer median of 2.0%.
SMTI Competitors
Other Income / Expenses for SMTI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TRDAEntrada Therapeutics, Inc.LTM Mar 2026$13.26M USD-32.7%+71.0%231.0%
NEONeoGenomics, Inc.LTM Jun 2026$11.62M USD+21.0%—1.5%
STXSStereotaxis, Inc.LTM Mar 2026-$317K USD-156.5%-1.0%1.0%
SGHTSight Sciences, Inc.LTM Mar 2026-$1.62M USD-403.6%—2.0%
VMDViemed Healthcare, Inc.LTM Mar 2026-$1.92M USD-5.1%+12.7%0.7%
LFMDLifeMD, Inc.LTM Mar 2026-$2M USD+14.1%—0.9%
XGNExagen Inc.LTM Mar 2026-$5.96M USD-298.1%—8.7%
SMTISanara MedTech Inc.LTM Mar 2026-$10.36M USD-136.8%—9.6%
TBRGTruBridge, Inc.LTM Mar 2026-$21.08M USD-21.0%—6.1%
HITIHigh Tide Inc.LTM Apr 2026-CA$42.77M CAD-322.5%—6.4%
Peer median (excluding SMTI) —-32.7%+12.7%2.0%

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue24.14M45.84M64.99M86.67M103.12M
Cost of Revenue2.31M6.36M7.85M8.14M10.18M
Gross Profit21.83M39.48M57.14M78.53M92.94M
Gross Margin90.4%86.1%87.9%90.6%90.1%
Research & Development558.7K3.37M4.13M5.7M5.07M
Selling, General & Admin28.05M45.98M56.99M76.56M78.72M
Operating Expenses29.21M52M61.35M85.25M83.79M
Depreciation & Amortization771.93K2.37M3.68M4.92M2.66M
EBITDA(7.22M)(11.57M)(289.1K)(1.86M)9.03M
EBITDA Margin-29.9%-25.2%-0.4%-2.1%8.8%
Operating Income(7.38M)(12.52M)(4.22M)(6.72M)9.15M
Operating Margin-30.6%-27.3%-6.5%-7.7%8.9%
Interest Income0284.75K021.98K3.67K
Interest Expense711284.75K475.78K3.13M6.76M
Other Income / Expenses(617.64K)(1.42M)(224.75K)(3.2M)(9.54M)
Income Before Tax(7.99M)(13.94M)(4.44M)(9.91M)(393.12K)
Pre-Tax Margin-33.1%-30.4%-6.8%-11.4%-0.4%
Income Tax Expense0(5.84M)000
Net Income(7.92M)(7.94M)(4.3M)(9.66M)(37.56M)
Net Margin-32.8%-17.3%-6.6%-11.2%-36.4%
EPS (Basic)(1.08)(1.00)(0.52)(1.14)(4.36)
EPS (Diluted)(1.08)(1.00)(0.52)(1.14)(4.36)
Weighted Avg Shares7.34M7.91M8.28M8.48M8.62M
Weighted Avg Shares (Diluted)7.34M7.91M8.28M8.48M8.62M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.